Treatment for PSA screen-detected prostate cancer: what are the options?
Oliver
R Tim D
RT
Institute of Cancer, Department of Experimental Cancer Medicine, St Barts & The London School of Medicine, Queen Mary University of London, London, UK. r.t.oliver@qmul.ac.uk
Neal
David E
DE
D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D008297:Male; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000401:mortality / Q000628:therapy*; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen